CREBBP is a Major Prognostic Biomarker for Relapse in Childhood B-cell Acute Lymphoblastic Leukemia: A National Study of Unselected Cohort

Although the identification of disease subtypes conveying prognostic significance along with minimal residual disease (MRD) assessment represent cornerstones for stratification in childhood acute lymphoblastic leukemia (ALL), approximately half of the relapses occur in patients from standard-risk gr...

Full description

Bibliographic Details

Published in:	Balkan Journal of Medical Genetics
Main Authors:	Krstevska Bozhinovikj E, Matevska-Geshkovska N, Staninova Stojovska M, Gjorgievska E, Jovanovska A, Kocheva S, Dimovski A
Format:	Article
Language:	English
Published:	Sciendo 2025-03-01
Subjects:	acute lymphoblastic leukemia relapse molecular biomarkers crebbp
Online Access:	https://doi.org/10.2478/bjmg-2024-0020